AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 19 filers reported holding AZIYO BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496 | -39.8% | 347,198 | -0.5% | 0.49% | -31.5% |
| Q2 2023 | $824 | +98.1% | 348,948 | +26.7% | 0.72% | +83.2% |
| Q1 2023 | $416 | -62.2% | 275,329 | +6.3% | 0.39% | -66.3% |
| Q4 2022 | $1,101 | -99.9% | 259,079 | +18.7% | 1.16% | -33.9% |
| Q3 2022 | $1,572,000 | -1.9% | 218,329 | -3.7% | 1.76% | +6.0% |
| Q2 2022 | $1,603,000 | +18.3% | 226,729 | -0.4% | 1.66% | +49.3% |
| Q1 2022 | $1,355,000 | -5.6% | 227,729 | 0.0% | 1.11% | +14.7% |
| Q4 2021 | $1,435,000 | -9.7% | 227,729 | -0.3% | 0.97% | -1.5% |
| Q3 2021 | $1,589,000 | +7.1% | 228,425 | +47.9% | 0.98% | +16.9% |
| Q2 2021 | $1,484,000 | -22.7% | 154,425 | +11.2% | 0.84% | -24.1% |
| Q1 2021 | $1,920,000 | +1.1% | 138,925 | -0.3% | 1.11% | -10.7% |
| Q4 2020 | $1,900,000 | – | 139,375 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
| PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
| Prosight Management, LP | 196,443 | $296,629 | 0.14% |
| Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
| Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
| Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
| US BANCORP \DE\ | 625 | $944 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |